LymphedemaV1, PubMed, Checkpoint, bibRecord, 001549

Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.

Identifieur interne : 001549 ( PubMed/Checkpoint ); précédent : 001548; suivant : 001550

Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.

Auteurs : William J. Kisoka [Tanzanie] ; Paul E. Simonsen [Danemark] ; Mwelecele N. Malecela [Tanzanie] ; Britt P. Tersb L [Danemark] ; Declare L. Mushi [Tanzanie] ; Dan W. Meyrowitsch [Danemark]

Source :

PloS one [ 1932-6203 ] ; 2014.

RBID : pubmed:25296034

Descripteurs français

KwdFr :
- Acceptation des soins par le patient (), Adolescent, Adulte, Albendazole (usage thérapeutique), Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Ivermectine (usage thérapeutique), Jeune adulte, Mâle, Population rurale (), Population urbaine (), Tanzanie (épidémiologie), Études transversales.
MESH :
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Ivermectine.
- épidémiologie : Filariose lymphatique, Tanzanie.
- Acceptation des soins par le patient, Adolescent, Adulte, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Mâle, Population rurale, Population urbaine, Études transversales.

English descriptors

KwdEn :
- Adolescent, Adult, Albendazole (therapeutic use), Child, Child, Preschool, Cross-Sectional Studies, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Female, Humans, Ivermectin (therapeutic use), Male, Patient Acceptance of Health Care (statistics & numerical data), Rural Population (statistics & numerical data), Tanzania (epidemiology), Urban Population (statistics & numerical data), Young Adult.
MESH :
- chemical , therapeutic use : Albendazole, Ivermectin.
- geographic , epidemiology : Tanzania.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- statistics & numerical data : Patient Acceptance of Health Care, Rural Population, Urban Population.
- Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Male, Young Adult.

Abstract

In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania.

DOI: 10.1371/journal.pone.0109316
PubMed: 25296034

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001269
to stream PubMed, to step Curation: 001269

Links to Exploration step

pubmed:25296034

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.</title>
<author><name sortKey="Kisoka, William J" sort="Kisoka, William J" uniqKey="Kisoka W" first="William J" last="Kisoka">William J. Kisoka</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania; Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.</nlm:affiliation>
<country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>National Institute for Medical Research, Dar es Salaam, Tanzania; Tumaini University, Kilimanjaro Christian Medical University College, Moshi</wicri:regionArea>
<wicri:noRegion>Moshi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Malecela, Mwelecele N" sort="Malecela, Mwelecele N" uniqKey="Malecela M" first="Mwelecele N" last="Malecela">Mwelecele N. Malecela</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania.</nlm:affiliation>
<country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>National Institute for Medical Research, Dar es Salaam</wicri:regionArea>
<wicri:noRegion>Dar es Salaam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tersb L, Britt P" sort="Tersb L, Britt P" uniqKey="Tersb L B" first="Britt P" last="Tersb L">Britt P. Tersb L</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mushi, Declare L" sort="Mushi, Declare L" uniqKey="Mushi D" first="Declare L" last="Mushi">Declare L. Mushi</name>
<affiliation wicri:level="1"><nlm:affiliation>Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.</nlm:affiliation>
<country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>Tumaini University, Kilimanjaro Christian Medical University College, Moshi</wicri:regionArea>
<wicri:noRegion>Moshi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Meyrowitsch, Dan W" sort="Meyrowitsch, Dan W" uniqKey="Meyrowitsch D" first="Dan W" last="Meyrowitsch">Dan W. Meyrowitsch</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Public Health, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Public Health, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25296034</idno>
<idno type="pmid">25296034</idno>
<idno type="doi">10.1371/journal.pone.0109316</idno>
<idno type="wicri:Area/PubMed/Corpus">001269</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001269</idno>
<idno type="wicri:Area/PubMed/Curation">001269</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001269</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001269</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001269</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.</title>
<author><name sortKey="Kisoka, William J" sort="Kisoka, William J" uniqKey="Kisoka W" first="William J" last="Kisoka">William J. Kisoka</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania; Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.</nlm:affiliation>
<country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>National Institute for Medical Research, Dar es Salaam, Tanzania; Tumaini University, Kilimanjaro Christian Medical University College, Moshi</wicri:regionArea>
<wicri:noRegion>Moshi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Malecela, Mwelecele N" sort="Malecela, Mwelecele N" uniqKey="Malecela M" first="Mwelecele N" last="Malecela">Mwelecele N. Malecela</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania.</nlm:affiliation>
<country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>National Institute for Medical Research, Dar es Salaam</wicri:regionArea>
<wicri:noRegion>Dar es Salaam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tersb L, Britt P" sort="Tersb L, Britt P" uniqKey="Tersb L B" first="Britt P" last="Tersb L">Britt P. Tersb L</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mushi, Declare L" sort="Mushi, Declare L" uniqKey="Mushi D" first="Declare L" last="Mushi">Declare L. Mushi</name>
<affiliation wicri:level="1"><nlm:affiliation>Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.</nlm:affiliation>
<country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>Tumaini University, Kilimanjaro Christian Medical University College, Moshi</wicri:regionArea>
<wicri:noRegion>Moshi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Meyrowitsch, Dan W" sort="Meyrowitsch, Dan W" uniqKey="Meyrowitsch D" first="Dan W" last="Meyrowitsch">Dan W. Meyrowitsch</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Public Health, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Public Health, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Albendazole (therapeutic use)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross-Sectional Studies</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Ivermectin (therapeutic use)</term>
<term>Male</term>
<term>Patient Acceptance of Health Care (statistics & numerical data)</term>
<term>Rural Population (statistics & numerical data)</term>
<term>Tanzania (epidemiology)</term>
<term>Urban Population (statistics & numerical data)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par le patient ()</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Ivermectine (usage thérapeutique)</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Population rurale ()</term>
<term>Population urbaine ()</term>
<term>Tanzanie (épidémiologie)</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Tanzania</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term>
<term>Rural Population</term>
<term>Urban Population</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Tanzanie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Acceptation des soins par le patient</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Population rurale</term>
<term>Population urbaine</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25296034</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>10</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>10</Issue>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.</ArticleTitle>
<Pagination><MedlinePgn>e109316</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0109316</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A questionnaire based cross sectional household survey was carried out in two rural and two urban districts in Lindi and Morogoro regions shortly after the 2011 MDA. 3279 adults (≥15 years) were interviewed about personal characteristics, socio-economic status, MDA drug uptake among themselves and their children, reasons for taking/not taking drugs, and participation in previous MDA activities for LF control.</AbstractText>
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">The overall drug uptake rate was 55.1% (range of 44.5-75.6% between districts). There was no overall major difference between children (54.8%) and adults (55.2%) or between females (54.9%) and males (55.8%), but the role of these and other predictors varied to some extent between study sites. Major overall predictors of drug uptake among the interviewed adults were increasing age and history of previous drug uptake. Being absent from home during drug distribution was the main reason for not taking the drugs (50.2%) followed by clinical contraindications to treatment (10.8%), missing household visits of drug distributors (10.6%), and households not being informed about the distribution (9.0%).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Drug uptake relied more on easily modifiable provider-related factors than on individual perceptions and practices in the target population. Limited investments in appropriate timing, dissemination of accurate timing information to recipients and motivation of drug distributors to visit all households (repeatedly when residents are absent) are likely to have considerable potential for increasing drug uptake, in support of successful LF transmission elimination.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kisoka</LastName>
<ForeName>William J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo><Affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania; Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Simonsen</LastName>
<ForeName>Paul E</ForeName>
<Initials>PE</Initials>
<AffiliationInfo><Affiliation>Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Malecela</LastName>
<ForeName>Mwelecele N</ForeName>
<Initials>MN</Initials>
<AffiliationInfo><Affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tersbøl</LastName>
<ForeName>Britt P</ForeName>
<Initials>BP</Initials>
<AffiliationInfo><Affiliation>Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mushi</LastName>
<ForeName>Declare L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo><Affiliation>Tumaini University, Kilimanjaro Christian Medical University College, Moshi, Tanzania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Meyrowitsch</LastName>
<ForeName>Dan W</ForeName>
<Initials>DW</Initials>
<AffiliationInfo><Affiliation>Department of Public Health, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>70288-86-7</RegistryNumber>
<NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F4216019LN</RegistryNumber>
<NameOfSubstance UI="D015766">Albendazole</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int Health. 2011 Mar;3(1):22-6</RefSource>
<PMID Version="1">24038047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009 Aug 25;3(8):e412</RefSource>
<PMID Version="1">19707588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1995 Dec;89(6):653-63</RefSource>
<PMID Version="1">8745940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2005 Apr;99(3):253-65</RefSource>
<PMID Version="1">15829135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Third World Q. 2011;32(1):91-117</RefSource>
<PMID Version="1">21591302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2010 Feb;15(2):224-31</RefSource>
<PMID Version="1">20002615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Res. 2013 Jan;112(1):35-44</RefSource>
<PMID Version="1">23239094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2006 Jun;11(6):862-8</RefSource>
<PMID Version="1">16772008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 1995 Dec;60(3):179-87</RefSource>
<PMID Version="1">8907396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2007 May;101(5):445-53</RefSource>
<PMID Version="1">17125809</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:395-441</RefSource>
<PMID Version="1">16735170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Nov;7(11):e2447</RefSource>
<PMID Version="1">24278486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1981 Aug;75(4):415-31</RefSource>
<PMID Version="1">6118103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Dec;77(6):1069-73</RefSource>
<PMID Version="1">18165524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2008 Dec;102(12):1207-13</RefSource>
<PMID Version="1">18632125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2013;13:335</RefSource>
<PMID Version="1">23870103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2004 Jun;9(6):702-9</RefSource>
<PMID Version="1">15189460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2011 Sep;120 Suppl 1:S48-54</RefSource>
<PMID Version="1">20932818</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2001 Dec 21;80(3):215-21</RefSource>
<PMID Version="1">11700178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biosoc Sci. 2013 Jul;45(4):517-45</RefSource>
<PMID Version="1">23014581</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2008 May 27;1(1):14</RefSource>
<PMID Version="1">18505577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(11):e48395</RefSource>
<PMID Version="1">23185256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2004 Apr;4(4):223-34</RefSource>
<PMID Version="1">15050941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2002 May;66(5):550-9</RefSource>
<PMID Version="1">12201589</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013636" MajorTopicYN="N" Type="Geographic">Tanzania</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014505" MajorTopicYN="N">Urban Population</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4190414</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>05</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>10</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>10</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>10</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25296034</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0109316</ArticleId>
<ArticleId IdType="pii">PONE-D-14-15147</ArticleId>
<ArticleId IdType="pmc">PMC4190414</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Danemark</li>
<li>Tanzanie</li>
</country>
<region><li>Hovedstaden</li>
</region>
<settlement><li>Copenhague</li>
</settlement>
</list>
<tree><country name="Tanzanie"><noRegion><name sortKey="Kisoka, William J" sort="Kisoka, William J" uniqKey="Kisoka W" first="William J" last="Kisoka">William J. Kisoka</name>
</noRegion>
<name sortKey="Malecela, Mwelecele N" sort="Malecela, Mwelecele N" uniqKey="Malecela M" first="Mwelecele N" last="Malecela">Mwelecele N. Malecela</name>
<name sortKey="Mushi, Declare L" sort="Mushi, Declare L" uniqKey="Mushi D" first="Declare L" last="Mushi">Declare L. Mushi</name>
</country>
<country name="Danemark"><region name="Hovedstaden"><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
</region>
<name sortKey="Meyrowitsch, Dan W" sort="Meyrowitsch, Dan W" uniqKey="Meyrowitsch D" first="Dan W" last="Meyrowitsch">Dan W. Meyrowitsch</name>
<name sortKey="Tersb L, Britt P" sort="Tersb L, Britt P" uniqKey="Tersb L B" first="Britt P" last="Tersb L">Britt P. Tersb L</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001549 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001549 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:25296034
   |texte=   Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:25296034" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.

Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki